<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30043917</article-id><article-id pub-id-type="pmc">6089129</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0232</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Extended-time of Noninvasive Positive Pressure Ventilation Improves
Tissue Perfusion after Coronary Artery Bypass Surgery: a Randomized Clinical
Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nasrala</surname><given-names>Mara L. S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><role>PT, MSc</role></contrib><contrib contrib-type="author"><name><surname>Bolzan</surname><given-names>Douglas W.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PT, PhD</role></contrib><contrib contrib-type="author"><name><surname>Lage</surname><given-names>Yumi G.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>PT</role></contrib><contrib contrib-type="author"><name><surname>Prado</surname><given-names>Fabiana S.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>PT</role></contrib><contrib contrib-type="author"><name><surname>Arena</surname><given-names>Ross</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>PT, PhD</role></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>Paulo R. L.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Feguri</surname><given-names>Gibran</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><role>MD, MSc</role></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Ageo M. C.</given-names></name><xref ref-type="aff" rid="aff5">5</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Marcondi</surname><given-names>Natasha O.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PT, MSc</role></contrib><contrib contrib-type="author"><name><surname>Hossne</surname><given-names>Nelson</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Guizilini</surname><given-names>Solange</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="corresp" rid="c1"/><role>PT, PhD</role></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Walter J.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Cardiology and Cardiovascular Surgery Disciplines, Escola Paulista
de Medicina, Universidade Federal de S&#x000e3;o Paulo (EPM-UNIFESP), S&#x000e3;o
Paulo, SP, Brazil.</aff><aff id="aff2">
<label>2</label>Physical Therapy Department, Hospital Santa Rosa, Cuiab&#x000e1;, MT,
Brazil.</aff><aff id="aff3">
<label>3</label>Physical Therapy Department, Hospital S&#x000e3;o Mateus,
Cuiab&#x000e1;, MT, Brazil.</aff><aff id="aff4">
<label>4</label>Department of Physical Therapy, College of Applied Health Sciences,
University of Illinois Chicago, Chicago, IL, USA.</aff><aff id="aff5">
<label>5</label>Public Health Department, Universidade Federal do Mato Grosso
(UFMT), Cuiab&#x000e1;, MT, Brazil.</aff><aff id="aff6">
<label>6</label>Department of the Human Movement Sciences, Universidade Federal de
S&#x000e3;o Paulo (UNIFESP), S&#x000e3;o Paulo, SP, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Solange Guizilini, Department of Human
Movement Sciences - Universidade Federal de S&#x000e3;o Paulo, Rua Silva Jardim,
136, Edif&#x000ed;cio Central - Santos, SP, Brasil - Zip code: 11015-020. E-mail:
<email>s_guizilini@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2018</year></pub-date><volume>33</volume><issue>3</issue><fpage>250</fpage><lpage>257</lpage><history><date date-type="received"><day>23</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>20</day><month>2</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To compare the effects of extended- <italic>versus</italic> short-time
noninvasive positive pressure ventilation on pulmonary function, tissue
perfusion, and clinical outcomes in the early postoperative period following
coronary artery bypass surgery in patients with preserved left ventricular
function.</p></sec><sec><title>Methods</title><p>Patients were randomized into two groups according to noninvasive positive
pressure ventilation intensity: short-time noninvasive positive pressure
ventilation n=20 (S-NPPV) and extended-time noninvasive positive pressure
ventilation n=21 (E-NPPV). S-NPPV was applied for 60 minutes during
immediate postoperative period and 10 minutes, twice daily, from
postoperative days 1-5. E-NPPV was performed for at least six hours during
immediate postoperative period and 60 minutes, twice daily, from
postoperative days 1-5. As a primary outcome, tissue perfusion was
determined by central venous oxygen saturation and blood lactate level
measured after anesthetic induction, immediately after extubation and
following noninvasive positive pressure ventilation protocols. As a
secondary outcome, pulmonary function tests were performed preoperatively
and in the postoperative days 1, 3, and 5; clinical outcomes were recorded.
</p></sec><sec><title>Results</title><p>Significant drop in blood lactate levels and an improvement in central venous
oxygen saturation values in the E-NPPV group were observed when compared
with S-NPPV group after study protocol (<italic>P</italic>&#x0003c;0.01). The
E-NPPV group presented higher preservation of postoperative pulmonary
function as well as lower incidence of respiratory events and shorter
postoperative hospital stay (<italic>P</italic>&#x0003c;0.05).</p></sec><sec><title>Conclusion</title><p>Prophylactic E-NPPV administered in the early postoperative period of
coronary artery bypass surgery resulted in greater improvements in tissue
perfusion, pulmonary function and clinical outcomes than S-NPPV, in patients
with preserved left ventricular function.</p></sec><sec><title>Trial Registration</title><p>Brazilian Registry of Clinical trial - RBR7sqj78 - <ext-link ext-link-type="uri" xlink:href="http://www.ensaiosclinicos.gov.br">http://www.ensaiosclinicos.gov.br</ext-link>
</p></sec></abstract><kwd-group><kwd>Coronary Artery Bypass</kwd><kwd>Lactic Acid/Blood</kwd><kwd>Lung/Physiology</kwd><kwd>Forced Expiratory Volume</kwd><kwd>Positive-Pressure Respiration.</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="42%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="42%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" colspan="2" style="background-color:#e6e7e8" rowspan="1">&#x000a0;</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BIPAP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Bilevel positive airway
pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IPO</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Immediate postoperative
period</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left internal thoracic
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
surgery</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LVEF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left ventricular
ejection fraction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NPPV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Noninvasive positive
pressure ventilation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CVP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central venous
pressure</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PEEP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Positive end-expiratory
pressure</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">E-NPPV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Extended-time
noninvasive positive pressure ventilation</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">POD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Postoperative day</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FEV<sub>1</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Forced expiratory volume
in 1 second</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ScvO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Central venous oxygen
saturation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FiO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Inspired oxygen
fraction</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">S-NPPV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Short-time noninvasive
positive pressure ventilation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FVC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Forced vital
capacity</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SpO<sub>2</sub></td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Arterial oxygen
saturation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive care unit</td><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Elevated blood lactate level and low central venous oxygen saturation
(ScvO<sub>2</sub>) have been independently associated with an increased risk of
complications and longer postoperative hospital stay following cardiac surgery,
contributing to increased morbidity and mortality after coronary artery bypass
surgery (CABG)<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>-</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>. In addition, several studies have shown that
postoperative pulmonary dysfunction following CABG is inevitable, which could
increase the occurrence of respiratory complications and delay
recovery<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>-</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>.</p><p>Noninvasive positive pressure ventilation (NPPV) has been used to accelerate the
recovery of pulmonary function as well as to prevent and treat postoperative
pulmonary complications. Previous evidence indicates a significant drop in blood
lactate concentration 60 minutes following NPPV<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>.</p><p>To date, no study has addressed the influence of early use of NPPV on key measures
and clinical outcomes following cardiac surgery. In this context, the aim of the
current study was to compare the effects of extended- <italic>versus</italic>
short-time prophylactic NPPV, applied in the early postoperative period following
CABG, on pulmonary function parameters, tissue perfusion determined by
ScvO<sub>2</sub>, blood lactate level, and clinical outcomes. We hypothesized
that NPPV would provide numerous beneficial effects and that the extended-time mode
would be superior to short-time NPPV.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This randomized controlled trial was conducted between June 2013 and May 2014, at
Santa Rosa and S&#x000e3;o Mateus Hospitals, Brazil. All ethical aspects were
respected, with approval of the institutions' Clinical Ethical Research Committees.
All subjects were informed about the study and they have signed a written consent
form prior to the enrollment.</p><sec><title>Patients</title><p>Patients undergoing elective first-time on-pump CABG were prospectively included
in the current study. Inclusion criteria were: both genders and 18 years of age
or older. Inability to perform spirometry, hemodynamic instability, left
ventricular ejection fraction less than 45%, emergency surgery, chronic or acute
pulmonary disease, intraoperative death, renal failure (creatinine &#x0003e; 1.3
mg/dL), anatomical abnormalities interfering with NPPV mask fit, obesity
[<italic>i.e</italic>., body mass index (BMI) &#x0003e; 30], steroid treatment,
and uncooperative state served as primary exclusion criteria.</p><p>The patients were prospectively randomized into two groups: short-time NPPV
(S-NPPV; n=20) and extended-time NPPV (E-NPPV; n=21). A random sequence was
performed through a software on "random.org" and allocation secrecy was kept by
numbered, sealed, opaque envelopes.</p></sec><sec><title>Surgical Procedure</title><p>All patients received the same anesthetic regimen during CABG. Anesthesia was
induced in a routine manner with etomidate and midazolam and maintained with
fentanyl and sevoflurane (0.5% to 1%). Mechanical ventilation was started with
volume-controlled ventilation at the following settings: 1) tidal volume at 8
ml/kg of predicted body weight; 2) positive end-expiratory pressure (PEEP) at 0
cmH<sub>2</sub>O; 3) inspiration/expiration ratio at 1:2; 4) inspired oxygen
fraction (FiO<sub>2</sub>) set to keep oxygen saturation above 90%; and 5)
respiratory rate adjusted to achieve a PaCO<sub>2</sub> between 35 and 45 mmHg.
During the operation, mean arterial pressure, central venous pressure (CVP),
arterial blood gas, temperature, urine output, electrocardiography, and heart
rate were continuously monitored.</p><p>Operation was performed through a median sternotomy, using the left internal
thoracic artery (LITA) graft, which was harvested according to the skeletonized
technique and complemented with additional saphenous vein grafts. Meticulous
care was routinely taken to preserve the pleura integrity during LITA
harvesting. In all patients, before chest closure, in the presence of incidental
left pleura opening, a soft tubular PVC drain was inserted and exteriorized at
the subxiphoid region and positioned in the left costophrenic sinus. In all
subjects, a mediastinal drain was also placed via a subxiphoid entry.</p><p>Cardiopulmonary bypass (CPB) was established with ascending aorta cannulation and
single cannula venous drainage, after systemic heparinization to keep the
activated coagulation time above 480 seconds. Myocardial protection was achieved
using intermittent hypothermic antegrade blood cardioplegia, associated with
systemic mild hypothermia (34&#x000ba;C).</p></sec><sec><title>Postoperative Management</title><p>All patients were transferred to the intensive care unit (ICU) and ventilated on
volume-controlled ventilation using the following parameters: 12-14
breaths/minute with a FiO<sub>2</sub> level set to maintain arterial oxygen
saturation (SpO<sub>2</sub>) above 90%; inspiratory/expiratory ratio of 1:2;
PEEP of 5 cmH<sub>2</sub>O; and pressure support to maintain a tidal volume of 8
ml/kg of predicted body weight. Extubation was performed when patients were
hemodynamically stable and alert to maintain self-ventilation and good blood gas
values. All patients received the same analgesic protocol (100 mg of tramadol
chlorhydrate, 4 times a day) administered until postoperative day (POD) 5.
Patients also underwent daily physical therapy sessions until discharge. Chest
tubes were routinely removed on POD2 and patients had daily chest X-ray.</p></sec><sec><title>Study Design</title><p>Following extubation, all E-NPPV patients received NPPV with bilevel positive
airway pressure (BIPAP) for at least six hours in the immediate postoperative
period (IPO) and 60 minutes, twice a day, from POD1 to POD5. S-NPPV patients
received NPPV with BIPAP administered for 1 hour in the IPO period and 10
minutes, twice a day, from POD1 to POD5, according to the ICU routine. In both
groups, during NPPV application, patients were in semi-recumbent position, with
the head of the bed elevated at 45&#x000b0;. BiPAP(r) Synchrony(r) equipment
(Respironics) was used with an adjustable face mask with the following
parameters: inspiratory positive airway pressure sufficient to ensure a tidal
volume of 8 ml/kg; and PEEP of 10 cmH<sub>2</sub>O with FiO<sub>2</sub> adjusted
to maintain SpO<sub>2</sub>&#x0003e;90%.</p></sec><sec><title>End Points</title><p>As a primary outcome, tissue perfusion was determined by ScvO<sub>2</sub> and
blood lactate level. As a secondary outcome, pulmonary function and clinical
outcomes were assessed.</p></sec><sec><title>Tissue Perfusion</title><p>For tissue perfusion analysis, blood samples directly drawn from the CVP catheter
were analyzed to assess the ScvO<sub>2</sub> and, simultaneously, blood samples
collected from the arterial catheter were used to evaluate blood lactate levels.
Low ScvO<sub>2</sub> was defined as &#x0003c;65% and hyperlactatemia was defined as a
blood lactate level &#x0003e;3 mmol/l. Blood samples were collected in three moments
at the IPO: intraoperative period (after anesthesia induction and invasive
mechanical ventilation), immediately after extubation (spontaneous ventilation),
and immediately after the NPPV protocol.</p></sec><sec><title>Pulmonary Function</title><p>Forced vital capacity (FVC) and forced expiratory volume in 1 second
(FEV<sub>1</sub>) were evaluated at the bedside on the day before the
operation and repeated on POD1, 3, and 5 (after NPPV protocols) by the same
respiratory physiotherapist, using a portable spirometer (Spirobank G, MIR,
Rome, Italy), according to the American Thoracic Society
standards<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>.</p></sec><sec><title>Clinical Outcomes</title><p>Length of mechanical ventilation and duration of postoperative hospital stay were
recorded for all patients. A radiologist who was blinded to subject group
allocation evaluated chest roentgenograms taken preoperatively and through POD1
to POD5. Respiratory events were also evaluated (atelectasis, pleural effusions,
and pneumonia). Pleural effusion was considered relevant when exceeding the
phreno-costal angle and fluid drainage was monitored
hourly<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. Atelectasis was acknowledged when a clear
atelectasis radiological shadow exceeded 15 mm in width<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>; linear atelectasis
was disregarded in this study. Pneumonia was defined by the presence on chest
radiographs with new or persistent pulmonary infiltrates not otherwise
explained, in combination with at least two of the following criteria: body
temperature of &#x0003e;38&#x000b0;C; leukocytosis (&#x0003e;10,000 cells/mm<sup>3</sup>); and
purulent respiratory secretions<sup>[</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>]</sup>. Assessors blinded to group allocation
documented the incidence of respiratory events.</p></sec><sec><title>Statistical Analysis</title><p>Data are reported as mean &#x000b1; standard deviation. Based on previous
studies<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>, sample size calculation was based on FVC at
POD1, considering a significance level of 5% and 80% power to detect a
difference between groups of at least a 400 ml decrease compared to the
preoperative period. This assumption suggested a sample of 40 patients,
resulting in a total of 60 patients recruited to account for patients not
completing the study<sup>[</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>. Initially, the Kolgomorov-Smirnov test was
applied to determine the distribution of variables. When variables were compared
between groups, we used the unpaired Student's t-test; and Mann-Whitney test was
used when deemed necessary. For intragroup analysis, we used the paired
Student's t-test; and ANOVA was used for repeated measures, as appropriate. For
categorical data, the Pearson's chi-square test was performed. The Pearson
correlation coefficient was used to evaluate associations.</p><p>In this study, clinically relevant threshold values of 3 mmol/l for blood lactate
level and 65% for the ScvO<sub>2</sub> were used. Trend analysis of these
variables was performed using simple linear regression models. The construction
of scatter plots of the variables showed in all cases that a linear evaluation
could be assumed, which supported the use of this model. Simple linear
regression models were adjusted for each group. As a measure of precision of
these models, we used the coefficient of determination (r<sup>2</sup>), later
transformed into Pearson's correlation coefficient. Statistical analysis was
performed by computerized statistical program (SPSS13.0, Chicago, IL, USA)
software. For all statistical tests, a <italic>P</italic>-value &#x0003c;0.05 defined
statistical significance.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>During the study period, 70 patients were assessed for eligibility. From that sample,
16 were excluded, 54 were randomized, and 41 were, in fact, analyzed (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart of consecutive CABG patients enrolled in the study.</p><p>CABG=coronary artery bypass surgery; COPD=chronic obstructive pulmonary
disease; E-NPPV=extended-time noninvasive positive pressure ventilation;
LV=left ventricular; PO=postoperative; S-NPPV=short-time noninvasive
positive pressure ventilation</p></caption><graphic xlink:href="rbccv-33-03-0250-g01"/></fig>
</p><p>The groups were homogeneous; pre- and intraoperative patients' characteristics are
summarized in <xref rid="t1" ref-type="table">Table 1</xref>. Following extubation,
patients in the E-NPPV group received prophylactic NPPV for 6.21&#x000b1;0.44
hours.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Pre- and intraoperative patients' characteristics.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">S-NPPV Group<break/>(n=20)</th><th align="center" rowspan="1" colspan="1">E-NPPV Group<break/>(n=21)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">59.7&#x000b1;11.4</td><td align="center" rowspan="1" colspan="1">58.6&#x000b1;7.3</td><td align="center" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">Men % (n)</td><td align="center" rowspan="1" colspan="1">85.0 (17)</td><td align="center" rowspan="1" colspan="1">76.2 (16)</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">27.4&#x000b1;5.0</td><td align="center" rowspan="1" colspan="1">27.7&#x000b1;4.0</td><td align="center" rowspan="1" colspan="1">0.80</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">61.2&#x000b1;14.6</td><td align="center" rowspan="1" colspan="1">63.0&#x000b1;11.3</td><td align="center" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB time (min)</td><td align="center" rowspan="1" colspan="1">71.1&#x000b1;19.9</td><td align="center" rowspan="1" colspan="1">70.5&#x000b1;27.0</td><td align="center" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" rowspan="1" colspan="1">Aortic cross-clamp time (min)</td><td align="center" rowspan="1" colspan="1">55.2&#x000b1;15.2</td><td align="center" rowspan="1" colspan="1">53.2&#x000b1;20.5</td><td align="center" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" rowspan="1" colspan="1">Operative time (h)</td><td align="center" rowspan="1" colspan="1">4.2&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">3.7&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td align="left" rowspan="1" colspan="1">Grafts per patient (n)</td><td align="center" rowspan="1" colspan="1">2.9&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">2.6&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary function</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;FVC (l)</td><td align="center" rowspan="1" colspan="1">3.3&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">3.1&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">94.21&#x000b1;18.2</td><td align="center" rowspan="1" colspan="1">91.72&#x000b1;15.9</td><td align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;FEV<sub>1</sub> (l)</td><td align="center" rowspan="1" colspan="1">2.8&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">2.9&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;% predicted</td><td align="center" rowspan="1" colspan="1">88.7&#x000b1;18.0</td><td align="center" rowspan="1" colspan="1">90.1&#x000b1;16.1</td><td align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pleurotomy % (n)</td><td align="center" rowspan="1" colspan="1">15.0 (3)</td><td align="center" rowspan="1" colspan="1">9.5 (2)</td><td align="center" rowspan="1" colspan="1">0.30</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Data are shown as mean &#x000b1; standard deviation.</p><p>BMI=body mass index; CPB=cardiopulmonary bypass; E-NPPV=extended-time
noninvasive positive pressure ventilation; FEV1=forced expiratory volume
in 1 second; FVC=forced vital capacity; LVEF=left ventricular ejection
fraction; S-NPPV=short-time noninvasive positive pressure
ventilation</p></fn></table-wrap-foot></table-wrap><p>A significant increase in blood lactate levels and a drop of ScvO<sub>2</sub> were
observed in both groups after extubation in comparison with pre-anesthetic values
(<italic>P</italic>&#x0003c;0.05). A strong negative correlation (r=-0.84) was
observed between blood lactate levels and ScvO<sub>2</sub> after trend analysis by
linear regression, with all patients breathing spontaneously (before NPPV
application) during the IPO period (<italic>P</italic>&#x0003c;0.001).</p><p>After NPPV, a significant drop in blood lactate levels and an improvement in
ScvO<sub>2</sub> values were observed in the E-NPPV group when compared with
S-NPPV group (<italic>P</italic>&#x0003c;0.05) (<xref ref-type="fig" rid="f2">Figures
2</xref> and <xref ref-type="fig" rid="f3">3</xref>, respectively).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Sequential changes of blood lactate level before and after NPPV.</p><p>*P&#x0003c;0.05.</p><p>A=intraoperative (after anesthesia induction and invasive mechanical
ventilation); B=before NPPV (spontaneous ventilation); C=after NPPV
(immediately after NPPV protocol); E-NPPV=extended-time noninvasive
positive pressure ventilation; S-NPPV=short-time noninvasive positive
pressure ventilation</p></caption><graphic xlink:href="rbccv-33-03-0250-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Sequential changes of ScvO<sub>2</sub> before and after NPPV.</p><p>*P&#x0003c;0.05.</p><p>A=intraoperative (after anesthesia induction and invasive mechanical
ventilation); B=before NPPV (spontaneous ventilation); C=after NPPV
(immediately after NPPV protocol); E-NPPV=extended-time noninvasive
positive pressure ventilation; S-NPPV=short-time noninvasive positive
pressure ventilation; ScvO<sub>2</sub>=central venous oxygen
saturation</p></caption><graphic xlink:href="rbccv-33-03-0250-g03"/></fig>
</p><p>In patients with blood lactate levels above 3 mmol/l (considering baseline values as
100%) during the IPO period, the use of E-NPPV lead to a 30.3% reduction in blood
lactate levels. Conversely, the S-NPPV group demonstrated a 15.6% decline in blood
lactate levels during the IPO period. In patients with ScvO<sub>2</sub> values below
65% during the IPO period (considering baseline values as 100%), E-NPPV was able to
increase in 23.3% the ScvO<sub>2</sub> values, while in the S-NPPV group a 1.2%
further decline was seen.</p><p>In <xref ref-type="fig" rid="f4">Figure 4</xref>, the distribution of both groups was
graphically analyzed regarding to blood lactate levels and ScvO<sub>2</sub> values.
Nine (45%) S-NPPV patients and two (9.5%) E-NPPV patients had blood lactate peak
above 3 mmol/l and ScvO<sub>2</sub> &#x0003c;65% (upper left quadrant). In the lower
right quadrant, 17 (80.9%) E-NPPV patients and eight (40%) S-NPPV patients showed
peak blood lactate levels below 3 mmol/l and ScvO<sub>2</sub> &#x0003e;65%.</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Patients' distribution according to cut-off values of 65%
(ScvO<sub>2</sub>) and 3 mmol/L (lactate) after NPPV protocol.</p><p>E-NPPV=extended-time noninvasive positive pressure ventilation;
S-NPPV=short-time noninvasive positive pressure ventilation;
ScvO<sub>2</sub>=central venous oxygen saturation</p></caption><graphic xlink:href="rbccv-33-03-0250-g04"/></fig>
</p><p>A significant impairment in FVC and FEV<sub>1</sub> until POD5 was observed in both
groups in comparison with the preoperative data (<italic>P</italic>&#x0003c;0.01).
However, the E-NPPV group presented with higher FVC and FEV<sub>1</sub> values on
POD1, 3 and 5 than the S-NPPV group. Significant differences were found in
FEV<sub>1</sub> on POD1 between these groups. FVC and FEV<sub>1</sub> were
significantly different between S-NPPV and E-NPPV groups on POD5 (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Pulmonary function test values on postoperative days (POD) 1, 3, and 5, in
percentage of preoperative values.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" colspan="2" rowspan="1">S-NPPV Group<break/>(n=20)</th><th align="center" colspan="2" rowspan="1">E-NPPV Group<break/>(n=21)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">FVC (%)</td><td align="center" rowspan="1" colspan="1">FEV<sub>1</sub> (%)</td><td align="center" rowspan="1" colspan="1">FVC (%)</td><td align="center" rowspan="1" colspan="1">FEV<sub>1</sub> (%)</td></tr><tr><td align="left" rowspan="1" colspan="1">POD1</td><td align="center" rowspan="1" colspan="1">43.34&#x000b1;13.8</td><td align="center" rowspan="1" colspan="1">45.32&#x000b1;15.7</td><td align="center" rowspan="1" colspan="1">54.34&#x000b1;24.5<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">55.84&#x000b1;12.4<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">POD3</td><td align="center" rowspan="1" colspan="1">47.34&#x000b1;19.9</td><td align="center" rowspan="1" colspan="1">49.91&#x000b1;17.5</td><td align="center" rowspan="1" colspan="1">65.56&#x000b1;17.4<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">72.38&#x000b1;15.1<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">POD5</td><td align="center" rowspan="1" colspan="1">67.75&#x000b1;16.3</td><td align="center" rowspan="1" colspan="1">58.04&#x000b1;12.0</td><td align="center" rowspan="1" colspan="1">79.87&#x000b1;18.5<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">80.45&#x000b1;16.3<xref ref-type="table-fn" rid="TFN3">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Data are shown as mean &#x000b1; standard deviation. FVC and FEV1 are
expressed in percentage considering 100% preoperative baseline
value.</p></fn><fn id="TFN3"><label>*</label><p><italic>P</italic>&#x0003c;0.05 for comparison between groups.</p></fn><fn id="TFN4"><p>E-NPPV=extended-time noninvasive positive pressure ventilation;
FEV<sub>1</sub>=forced expiratory volume in 1 second; FVC=forced
vital capacity; S-NPPV=short-time noninvasive positive pressure
ventilation</p></fn></table-wrap-foot></table-wrap><p>Hospital stay after CABG was significantly shorter in the E-NPPV group than in the
S-NPPV group (<italic>P</italic>&#x0003c;0.05). Moreover, the incidence of respiratory
events on POD5 was greater in the S-NPPV group than in the E-NPPV group (<xref rid="t3" ref-type="table">Table 3</xref>).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Postoperative clinical variables.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">S-NPPV Group<break/>(n=20)</th><th align="center" rowspan="1" colspan="1">E-NPPV Group<break/>(n=21)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Atelectasis % (n)</td><td align="center" rowspan="1" colspan="1">26.3 (5)</td><td align="center" rowspan="1" colspan="1">4.7 (1)<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pleural effusion % (n)</td><td align="center" rowspan="1" colspan="1">15.7 (3)</td><td align="center" rowspan="1" colspan="1">9.5 (2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pneumonia % (n)</td><td align="center" rowspan="1" colspan="1">15.7 (3)</td><td align="center" rowspan="1" colspan="1">4.7 (1)<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Mechanical ventilation time (h)</td><td align="center" rowspan="1" colspan="1">12.1&#x000b1;1.8</td><td align="center" rowspan="1" colspan="1">11.2&#x000b1;1.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative hospital stay (days)</td><td align="center" rowspan="1" colspan="1">8.1&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">6.9&#x000b1;1.3<xref ref-type="table-fn" rid="TFN6">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>Data are shown as mean &#x000b1; standard deviation. Comparison between
the groups</p></fn><fn id="TFN6"><label>*</label><p><italic>P</italic>&#x0003c;0.05. E-NPPV=extended-time noninvasive positive
pressure ventilation; S-NPPV=short-time noninvasive positive pressure
ventilation</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Prophylactic E-NPPV intervention demonstrated a positive impact on tissue perfusion,
preservation of pulmonary function, and clinical outcomes compared to S-NPPV in the
early postoperative period after CABG in this group of patients with preserved
cardiac function. To our knowledge, this is the first study comparing the
aforementioned outcomes between E-NPPV and S-NPPV after a major cardiac surgery.</p><p>A previous investigation<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup> demonstrated that the prophylactic use of E-NPPV is
able to promote a better improvement in arterial oxygenation and some clinical
outcomes than the S-NPPV. However, the above-mentioned study did not evaluate the
effects of NPPV on tissue perfusion. Another study<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup> suggested that NPPV
could be considered an effective and safe therapy to minimize dyspnea, improve
tissue perfusion, and decrease arrhythmia frequency, reintubation rate, length of
ICU stay, and mortality in patients after cardiac surgery when compared to oxygen
therapy alone. Therefore, the novel aspects of our study were the influence of
E-NPPV and S-NPPV application on tissue perfusion, pulmonary function, and clinical
outcomes in patients who underwent CABG.</p><p>Recently, an investigation documented that a significant impairment in tissue
perfusion (<italic>i.e</italic>. elevated lactate level and low ScvO<sub>2</sub>)
could delay operation recovery, increase the risk of complications, and lead to a
longer postoperative hospital stay, contributing to the risk of morbidity and
mortality following CABG<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>-</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>. As a result, special interest has been given to
strategies to improve tissue perfusion<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>.</p><p>In agreement with other studies<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>, our data revealed a significant increase in
blood lactate levels and impairment in ScvO<sub>2</sub> during the IPO period in
comparison with preoperative values. According to Ranucci et
al.<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>, ScvO<sub>2</sub> and blood lactate level used in
combination could be a clinical tool to help discern if an elevated lactate level is
due to hypoperfusion or other mechanisms. In our study, a strong negative
correlation supported the relationship between a ScvO<sub>2</sub> drop below 65% and
an increase in blood lactate levels. For this reason, we assume that blood lactate
levels found in the current study were associated with impairment in tissue
perfusion.</p><p>After NPPV application, there were a significant drop in blood lactate levels and a
significant improvement in ScvO<sub>2</sub> values in the E-NPPV group when compared
with the S-NPPV group. Based on these findings, we believe that NPPV was the
interventional mechanism for improvement in tissue perfusion in patients undergoing
CABG, in particular E-NPPV.</p><p>In general, some potential mechanisms may explain our findings. Firstly, we believe
that NPPV promoted a beneficial effect on cardiac function. After on-pump CABG,
early reperfusion precipitates a period of relative hemodynamic instability in which
small and rapid changes in ventricular loading, myocardial perfusion pressure, and
endogenous inotropic state can change global ventricular performance
considerably<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>. In addition, the early reperfusion period is
characterized by a high incidence of regional or global ventricular dysfunction.
Even in patients with a preoperative preserved ventricular function, a significant
ejection fraction reduction could be noted in the first four hours after
surgery<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>. Previous research has shown that NPPV application
in patients with cardiac dysfunction could increase cardiac index, systemic oxygen
delivery, and oxygen consumption<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>-</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>. Despite the fact that patients in the present
study had preserved cardiac function, we believe that NPPV could have prevented
acute cardiac alterations related to the operation. Secondly, studies have shown
experimentally that atelectasis causes a significant increase in right ventricular
afterload, thereby affecting left ventricular performance. This effect of
atelectasis on right ventricular afterload during mechanical ventilation could be
explained by two mechanisms: overdistention in aerated lung areas and local hypoxic
pulmonary vasoconstriction in non-aerated lung areas<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>,</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. In the current study,
the E-NPPV group demonstrated a lower prevalence of atelectasis than the S-NPPV
group. We speculate that E-NPPV reduced the risk of atelectasis and subsequently
right ventricular stress by a reduction in hypoxic pulmonary vasoconstriction.</p><p>Zarbock et al.<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup> demonstrated that prophylactic NPPV application at
least six hours after the operation increased pulmonary oxygen transfer, reduced
pulmonary complications, and also decreased ICU readmission rates following elective
cardiac surgery. Similar results were found in our study. The use of E-NPPV was
associated with a significantly better preservation of pulmonary function than the
S-NPPV.</p><p>A greater degree of pulmonary dysfunction increases the risk of pulmonary
complications during the CABG postoperative course, which may result in longer
postoperative hospital stay and increased mortality<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>-</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. These results are in
agreement with our findings; the S-NPPV group presented with a higher pulmonary
function impairment which was associated with a significantly greater intubation
time, occurrence of atelectasis, and pneumonia until POD5, and longer hospital stay
than the E-NPPV group.</p><p>We were able to show that E-NPPV application significantly preserved pulmonary
function and reduced respiratory events in patients deemed to be at low surgical
risk. The literature had demonstrated that high-risk patients could potentially have
more benefits with NPPV application<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>. Therefore, we speculate that the benefit of
E-NPPV in high-risk patients following cardiac surgery could be even more
pronounced, which may also lead to a more profound reduction in length of hospital
stay.</p><sec><title>Limitations</title><p>Our study has some limitations that should be highlighted. The duration (one
hour, twice a day) of NPPV after ICU discharge in the E-NPPV group may not have
been enough to promote a faster return of the pulmonary function to baseline
values. However, the E-NPPV protocol was able to promote a better preservation
of pulmonary function and to prevent postoperative complications when compared
to the S-NPPV.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Prophylactic E-NPPV administered in the early postoperative period of CABG resulted
in greater improvements in tissue perfusion, pulmonary function, and clinical
outcomes than S-NPPV in patients with preserved left ventricular function. These
findings hold clinical relevance and should be considered when developing the care
plan for individuals undergoing a major cardiac surgery.</p><table-wrap id="t5" orientation="portrait" position="float"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MLSN</td><td align="left" valign="top" rowspan="1" colspan="1">Concept, design, acquisition, analysis and
interpretation of data, critical review of the study; final approval
of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DWB</td><td align="left" valign="top" rowspan="1" colspan="1">Interpretation of data, and critical
review of the study; final approval of the manuscript version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">YGL</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition of data, final approval of the
manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FSP</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition of data, final approval of the
manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RA</td><td align="left" valign="top" rowspan="1" colspan="1">Critical review of the study, final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PRLL</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition of data, final approval of the
manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GF</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition of data, final approval of the
manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AMCS</td><td align="left" valign="top" rowspan="1" colspan="1">Analysis and interpretation of data; final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NOM</td><td align="left" valign="top" rowspan="1" colspan="1">Interpretation of data, critical review of
the study; final approval of the manuscript version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NH</td><td align="left" valign="top" rowspan="1" colspan="1">Critical review of the study, final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SG</td><td align="left" valign="top" rowspan="1" colspan="1">Concept, design, analysis and
interpretation of data, critical review of the study; final approval
of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WJG</td><td align="left" valign="top" rowspan="1" colspan="1">Concept, design, analysis and
interpretation of data, critical review of the study; final approval
of the manuscript version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Universidade Federal de Mato Grosso (UFMT),
Cuiab&#x000e1;, MT, Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="supported-by"><p>Financial support: Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado
de Mato Grosso.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>J</given-names></name><name><surname>Hakanson</surname><given-names>E</given-names></name><name><surname>V&#x000e1;nky</surname><given-names>F</given-names></name><name><surname>Svedjeholm</surname><given-names>R</given-names></name></person-group><article-title>Mixed venous oxygen saturation predicts short- and long-term
outcome after coronary artery bypass grafting surgery: a retrospective
cohort analysis</article-title><source>Br J Anaesth</source><year>2011</year><volume>107</volume><issue>3</issue><fpage>344</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">21680601</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiumello</surname><given-names>D</given-names></name><name><surname>Chevallard</surname><given-names>G</given-names></name><name><surname>Gregoretti</surname><given-names>C</given-names></name></person-group><article-title>Non-invasive ventilation in postoperative patients: a systematic
review</article-title><source>Intensive Care Med</source><year>2011</year><volume>37</volume><issue>6</issue><fpage>918</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">21424246</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>BY</given-names></name><name><surname>Laine</surname><given-names>GA</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Solis</surname><given-names>RT</given-names></name></person-group><article-title>Combined central venous oxygen saturation and lactate as markers
of occult hypoperfusion and outcome following cardiac
surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2012</year><volume>26</volume><issue>1</issue><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">21924630</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Alves</surname><given-names>DF</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Cancio</surname><given-names>AS</given-names></name><name><surname>Regenga</surname><given-names>MM</given-names></name><name><surname>Moreira</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Sub-xyphoid pleural drain as a determinant of functional capacity
and clinical results after off-pump coronary artery bypass surgery: a
randomized clinical trial</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2014</year><volume>19</volume><issue>3</issue><fpage>382</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">24899589</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Ferraz</surname><given-names>RF</given-names></name><name><surname>Tavolaro</surname><given-names>K</given-names></name><name><surname>Cancio</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Pleurotomy with subxyphoid pleural drain affords similar effects
to pleural integrity in pulmonary function after off-pump coronary artery
bypass graft</article-title><source>J Cardiothorac Surg</source><year>2012</year><volume>7</volume><fpage>11</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">22277597</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizilini</surname><given-names>S</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name><name><surname>Faresin</surname><given-names>SM</given-names></name><name><surname>Bolzan</surname><given-names>DW</given-names></name><name><surname>Buffolo</surname><given-names>E</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Influence of pleurotomy on pulmonary function after off-pump
coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>84</volume><issue>3</issue><fpage>817</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">17720381</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XF</given-names></name><name><surname>Ye</surname><given-names>JL</given-names></name></person-group><article-title>Efficacy and safety of non-invasive positive pressure ventilation
in the care of dyspnea after cardiac surgery</article-title><source>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</source><year>2007</year><volume>19</volume><issue>9</issue><fpage>542</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">17767824</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><article-title>Standardization of Spirometry, 1994 Update</article-title><person-group person-group-type="author"><collab>American Thoracic Society</collab></person-group><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>3</issue><fpage>1107</fpage><lpage>1136</lpage><pub-id pub-id-type="pmid">7663792</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>TF</given-names></name><name><surname>Sethi</surname><given-names>S</given-names></name></person-group><article-title>Bacterial infection in chronic obstructive pulmonary
disease</article-title><source>Am Rev Respir Dis</source><year>1992</year><volume>146</volume><issue>4</issue><fpage>1067</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">1416398</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>FS</given-names></name><name><surname>Terra-Filho</surname><given-names>M</given-names></name><name><surname>Hueb</surname><given-names>W</given-names></name><name><surname>Teixeira</surname><given-names>LR</given-names></name><name><surname>Cukier</surname><given-names>A</given-names></name><name><surname>Light</surname><given-names>RW</given-names></name></person-group><article-title>Pulmonary function after coronary artery bypass
surgery</article-title><source>Respir Med</source><year>1997</year><volume>91</volume><issue>10</issue><fpage>629</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">9488897</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarbock</surname><given-names>A</given-names></name><name><surname>Mueller</surname><given-names>E</given-names></name><name><surname>Netzer</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>A</given-names></name><name><surname>Feindt</surname><given-names>P</given-names></name><name><surname>Kindgen-Milles</surname><given-names>D</given-names></name></person-group><article-title>Prophylactic nasal continuous positive airway pressure following
cardiac surgery protects from postoperative pulmonary complications: a
prospective, randomized, controlled trial in 500 patients</article-title><source>Chest</source><year>2009</year><volume>135</volume><issue>5</issue><fpage>1252</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">19017864</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000f6;l&#x000f6;nen</surname><given-names>P</given-names></name><name><surname>Ruokonen</surname><given-names>E</given-names></name><name><surname>Hippel&#x000e4;inen</surname><given-names>M</given-names></name><name><surname>P&#x000f6;yh&#x000f6;nen</surname><given-names>M</given-names></name><name><surname>Takala</surname><given-names>J</given-names></name></person-group><article-title>A prospective, randomized study of goal-oriented hemodynamic
therapy in cardiac surgical patients</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><issue>5</issue><fpage>1052</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">10781452</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranucci</surname><given-names>M</given-names></name><name><surname>Isgr&#x000f2;</surname><given-names>G</given-names></name><name><surname>Carlucci</surname><given-names>C</given-names></name><name><surname>De La Torre</surname><given-names>T</given-names></name><name><surname>Enginoli</surname><given-names>S</given-names></name><name><surname>Frigiola</surname><given-names>A</given-names></name><collab>Surgical and Clinical Outcome REsearch Group</collab></person-group><article-title>Central venous oxygen saturation and blood lactate levels during
cardiopulmonary bypass are associated with outcome after pediatric cardiac
surgery</article-title><source>Crit Care</source><year>2010</year><volume>14</volume><issue>4</issue><fpage>R149</fpage><lpage>R149</lpage><pub-id pub-id-type="pmid">20684758</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>JM</given-names></name><name><surname>O'Kelly</surname><given-names>B</given-names></name><name><surname>Browner</surname><given-names>WS</given-names></name><name><surname>Tubau</surname><given-names>J</given-names></name><name><surname>Hollenberg</surname><given-names>M</given-names></name><name><surname>Mangano</surname><given-names>DT</given-names></name></person-group><article-title>Prognostic importance of postbypass regional wall-motion
abnormalities in patients undergoing coronary artery bypass graft
surgery</article-title><source>SPI Research Group. Anesthesiology</source><year>1989</year><volume>71</volume><issue>1</issue><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">2787609</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangano</surname><given-names>DT</given-names></name></person-group><article-title>Biventricular function after myocardial revascularization in
humans: deterioration and recovery patterns during the first 24
hours</article-title><source>Anesthesiology</source><year>1985</year><volume>62</volume><issue>5</issue><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">3873186</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallet</surname><given-names>RH</given-names></name><name><surname>Diaz</surname><given-names>JV</given-names></name></person-group><article-title>The physiologic effects of noninvasive
ventilation</article-title><source>Respir Care</source><year>2009</year><volume>54</volume><issue>1</issue><fpage>102</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">19111110</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acosta</surname><given-names>MF</given-names></name><name><surname>DiBenedetto</surname><given-names>R</given-names></name><name><surname>Rahimi</surname><given-names>A</given-names></name><name><surname>Acosta</surname><given-names>MF</given-names></name><name><surname>Cuadra</surname><given-names>O</given-names></name><name><surname>Van Nguyen</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hemodynamic effects of noninvasive bilevel positive airway
pressure on patients with chronic congestive heart failure with systolic
dysfunction</article-title><source>Chest</source><year>2000</year><volume>118</volume><issue>4</issue><fpage>1004</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">11035670</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baratz</surname><given-names>DM</given-names></name><name><surname>Westbrook</surname><given-names>PR</given-names></name><name><surname>Shah</surname><given-names>PK</given-names></name><name><surname>Mohsenifar</surname><given-names>Z</given-names></name></person-group><article-title>Effect of nasal continuous positive airway pressure on cardiac
output and oxygen delivery in patients with congestive heart
failure</article-title><source>Chest</source><year>1992</year><volume>102</volume><issue>5</issue><fpage>1397</fpage><lpage>1401</lpage><pub-id pub-id-type="pmid">1424858</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buda</surname><given-names>AJ</given-names></name><name><surname>Pinsky</surname><given-names>MR</given-names></name><name><surname>Ingels Jr</surname><given-names>NB</given-names></name><name><surname>GT 2nd</surname><given-names>Daughters</given-names></name><name><surname>Stinson</surname><given-names>EB</given-names></name><name><surname>Alderman</surname><given-names>EL</given-names></name></person-group><article-title>Effect of intrathoracic pressure on left ventricular
performance</article-title><source>N Engl J Med</source><year>1979</year><volume>301</volume><issue>9</issue><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">460363</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duggan</surname><given-names>M</given-names></name><name><surname>McCaul</surname><given-names>CL</given-names></name><name><surname>McNamara</surname><given-names>PJ</given-names></name><name><surname>Engelberts</surname><given-names>D</given-names></name><name><surname>Ackerley</surname><given-names>C</given-names></name><name><surname>Kavanagh</surname><given-names>BP</given-names></name></person-group><article-title>Atelectasis causes vascular leak and lethal right ventricular
failure in uninjured rat lungs</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><issue>12</issue><fpage>1633</fpage><lpage>1640</lpage><pub-id pub-id-type="pmid">12663325</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creamer</surname><given-names>KM</given-names></name><name><surname>McCloud</surname><given-names>LL</given-names></name><name><surname>Fisher</surname><given-names>LE</given-names></name><name><surname>Ehrhart</surname><given-names>IC.</given-names></name></person-group><article-title>Ventilation above closing volume reduces pulmonary vascular
resistance hysteresis</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>158</volume><issue>4</issue><fpage>1114</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">9769269</pub-id></element-citation></ref></ref-list></back></article>